An ongoing
Milwaukee Journal Sentinel/MedPage Today investigation into a
bone morphogenetic protein-2 device marketed as
Infuse has uncovered a number of concerns about the safety of the product. In this special report, Infuse patients tell their stories.
MedPage Today
No comments:
Post a Comment